Impact of clonal architecture on clinical course and prognosis in patients with myeloproliferative neoplasms
D. Luque Paz, M. S. Bader, R. Nienhold, S. Rai, T. Almeida Fonseca, J. Stetka, H. Hao-Shen, G. Mild-Schneider, J. R. Passweg, R. C. Skoda
The paper analyzes clonal architecture in MPN patients with multiple mutations to identify prognostic clusters and risk factors.
bioRxiv · Sep 24, 2022Cancer Biology